{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:46:42Z","timestamp":1792201602237,"version":"4.4.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T00:00:00Z","timestamp":1490918400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00125-017-4265-8","type":"journal-article","created":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T05:52:54Z","timestamp":1490939574000},"page":"1344-1353","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Women with prior gestational diabetes mellitus and prediabetes are characterised by a decreased incretin effect"],"prefix":"10.1007","volume":"60","author":[{"given":"Signe","family":"Foghsgaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Vedtofte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Andreasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie S.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Bahne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonatan I.","family":"Bagger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens A.","family":"Svare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens J.","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine D.","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth R.","family":"Mathiesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Damm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip K.","family":"Knop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Vilsb\u00f8ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,31]]},"reference":[{"key":"4265_CR1","volume-title":"Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO\/IDF consultation","author":"World Health Organization, International Diabetes Federation","year":"2006","unstructured":"World Health Organization, International Diabetes Federation (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO\/IDF consultation. WHO, Geneva"},{"key":"4265_CR2","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.2337\/diacare.27.5.1194","volume":"27","author":"J Lauenborg","year":"2004","unstructured":"Lauenborg J, Hansen T, Jensen DM et al (2004) Increasing incidence of diabetes after gestational diabetes: a long-term follow-up in a Danish population. Diabetes Care 27:1194\u20131199","journal-title":"Diabetes Care"},{"issue":"Suppl 2","key":"4265_CR3","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.2337\/dc07-s221","volume":"30","author":"JL Kitzmiller","year":"2007","unstructured":"Kitzmiller JL, Dang-Kilduff L, Taslimi MM (2007) Gestational diabetes after delivery. Short-term management and long-term risks. Diabetes Care 30(Suppl 2):S225\u2013S235","journal-title":"Diabetes Care"},{"key":"4265_CR4","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s00125-015-3615-7","volume":"58","author":"K Benhalima","year":"2015","unstructured":"Benhalima K, Mathieu C, Damm P et al (2015) A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG). Diabetologia 58:1422\u20131429","journal-title":"Diabetologia"},{"key":"4265_CR5","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.2337\/diacare.25.10.1862","volume":"25","author":"C Kim","year":"2002","unstructured":"Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25:1862\u20131868","journal-title":"Diabetes Care"},{"key":"4265_CR6","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/(SICI)1096-9136(199611)13:11<953::AID-DIA257>3.0.CO;2-V","volume":"13","author":"M Fern\u00e1ndez-Casta\u00f1er","year":"1996","unstructured":"Fern\u00e1ndez-Casta\u00f1er M, Biarn\u00e9s J, Camps I, Ripoll\u00e9s J, G\u00f3mez N, Soler J (1996) Beta-cell dysfunction in first-degree relatives of patients with non-insulin-dependent diabetes mellitus. Diabet Med J 13:953\u2013959","journal-title":"Diabet Med J"},{"key":"4265_CR7","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","volume":"383","author":"SE Kahn","year":"2014","unstructured":"Kahn SE, Cooper ME, Del Prato S (2014) Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet 383:1068\u20131083","journal-title":"Lancet"},{"key":"4265_CR8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF02427280","volume":"29","author":"M Nauck","year":"1986","unstructured":"Nauck M, St\u00f6ckmann F, Ebert R, Creutzfeldt W (1986) Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia 29:46\u201352","journal-title":"Diabetologia"},{"key":"4265_CR9","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00125-002-0878-6","volume":"45","author":"T Vilsb\u00f8ll","year":"2002","unstructured":"Vilsb\u00f8ll T, Krarup T, Madsbad S, Holst JJ (2002) Defective amplification of the late phase insulin response to glucose by GIP in obese type II diabetic patients. Diabetologia 45:1111\u20131119","journal-title":"Diabetologia"},{"key":"4265_CR10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.regpep.2013.08.002","volume":"186","author":"M Kosinski","year":"2013","unstructured":"Kosinski M, Knop FK, Vedtofte L et al (2013) Postpartum reversibility of impaired incretin effect in gestational diabetes mellitus. Regul Pept 186:104\u2013107","journal-title":"Regul Pept"},{"key":"4265_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003834","volume":"3","author":"S Foghsgaard","year":"2013","unstructured":"Foghsgaard S, Vedtofte L, Mathiesen ER et al (2013) The effect of a glucagon-like peptide-1 receptor agonist on glucose tolerance in women with previous gestational diabetes mellitus: protocol for an investigator-initiated, randomised, placebo-controlled, double-blinded, parallel intervention trial. BMJ Open 3:e003834. doi:\n10.1136\/bmjopen-2013-003834","journal-title":"BMJ Open"},{"key":"4265_CR12","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00125-014-3283-z","volume":"57","author":"NJ Wewer Albrechtsen","year":"2014","unstructured":"Wewer Albrechtsen NJ, Hartmann B, Veedfald S et al (2014) Hyperglucagonaemia analysed by glucagon sandwich ELISA: non-specific interference or truly elevated levels? Diabetologia 57:1919\u20131926","journal-title":"Diabetologia"},{"key":"4265_CR13","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1210\/jc.2011-0266","volume":"96","author":"O Lindgren","year":"2011","unstructured":"Lindgren O, Carr RD, Deacon CF et al (2011) Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans. J Clin Endocrinol Metab 96:2519\u20132524","journal-title":"J Clin Endocrinol Metab"},{"key":"4265_CR14","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2337\/diab.42.5.658","volume":"42","author":"C Orskov","year":"1993","unstructured":"Orskov C, Wettergren A, Holst JJ (1993) Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable. Diabetes 42:658\u2013661","journal-title":"Diabetes"},{"key":"4265_CR15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"4265_CR16","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2337\/diacare.21.12.2191","volume":"21","author":"JC Levy","year":"1998","unstructured":"Levy JC, Matthews DR, Hermans MP (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21:2191\u20132192","journal-title":"Diabetes Care"},{"key":"4265_CR17","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462\u20131470","journal-title":"Diabetes Care"},{"key":"4265_CR18","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/0026-0495(79)90146-X","volume":"28","author":"RC Turner","year":"1979","unstructured":"Turner RC, Holman RR, Matthews D, Hockaday TD, Peto J (1979) Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism 28:1086\u20131096","journal-title":"Metabolism"},{"key":"4265_CR19","doi-asserted-by":"crossref","first-page":"E832","DOI":"10.1152\/ajpendo.00700.2009","volume":"298","author":"KJ Hare","year":"2010","unstructured":"Hare KJ, Vilsb\u00f8ll T, Holst JJ, Knop FK (2010) Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes. Am J Physiol Endocrinol Metab 298:E832\u2013E837","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4265_CR20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2337\/diab.43.4.535","volume":"43","author":"C Orskov","year":"1994","unstructured":"Orskov C, Rabenh\u00f8j L, Wettergren A, Kofod H, Holst JJ (1994) Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes 43:535\u2013539","journal-title":"Diabetes"},{"key":"4265_CR21","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.2337\/db13-1951","volume":"63","author":"SF Michaliszyn","year":"2014","unstructured":"Michaliszyn SF, Mari A, Lee S et al (2014) \u03b2-Cell function, incretin effect, and incretin hormones in obese youth along the span of glucose tolerance from normal to prediabetes to type 2 diabetes. Diabetes 63:3846\u20133855","journal-title":"Diabetes"},{"key":"4265_CR22","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1463-1326.2011.01549.x","volume":"14","author":"FK Knop","year":"2012","unstructured":"Knop FK, Aaboe K, Vilsb\u00f8ll T et al (2012) Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity. Diabetes Obes Metab 14:500\u2013510","journal-title":"Diabetes Obes Metab"},{"issue":"Suppl 2","key":"4265_CR23","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.2337\/dc11-s227","volume":"34","author":"JJ Holst","year":"2011","unstructured":"Holst JJ, Knop FK, Vilsb\u00f8ll T, Krarup T, Madsbad S (2011) Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes. Diabetes Care 34(Suppl 2):S251\u2013S257","journal-title":"Diabetes Care"},{"key":"4265_CR24","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1007\/s00125-014-3264-2","volume":"57","author":"JI Bagger","year":"2014","unstructured":"Bagger JI, Knop FK, Lund A, Holst JJ, Vilsb\u00f8ll T (2014) Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals. Diabetologia 57:1720\u20131725","journal-title":"Diabetologia"},{"key":"4265_CR25","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.2337\/db14-1751","volume":"64","author":"K F\u00e6rch","year":"2015","unstructured":"F\u00e6rch K, Torekov SS, Vistisen D et al (2015) GLP-1 response to oral glucose is reduced in prediabetes, screen-detected type 2 diabetes, and obesity and influenced by sex: the ADDITION-PRO study. Diabetes 64:2513\u20132525","journal-title":"Diabetes"},{"key":"4265_CR26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJM199201023260104","volume":"326","author":"A Mitrakou","year":"1992","unstructured":"Mitrakou A, Kelley D, Mokan M et al (1992) Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326:22\u201329","journal-title":"N Engl J Med"},{"key":"4265_CR27","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00125-007-0899-2","volume":"51","author":"M Laakso","year":"2008","unstructured":"Laakso M, Zilinskaite J, Hansen T et al (2008) Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and\/or impaired glucose tolerance in the EUGENE2 study. Diabetologia 51:502\u2013511","journal-title":"Diabetologia"},{"key":"4265_CR28","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s00125-013-2956-3","volume":"56","author":"S Forbes","year":"2013","unstructured":"Forbes S, Godsland IF, Taylor-Robinson SD et al (2013) A history of previous gestational diabetes mellitus is associated with adverse changes in insulin secretion and VLDL metabolism independently of increased intrahepatocellular lipid. Diabetologia 56:2021\u20132033","journal-title":"Diabetologia"},{"key":"4265_CR29","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1007\/s00125-005-1863-7","volume":"48","author":"JJ Meier","year":"2005","unstructured":"Meier JJ, Gallwitz B, Askenas M et al (2005) Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes. Diabetologia 48:1872\u20131881","journal-title":"Diabetologia"},{"key":"4265_CR30","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00125-013-2841-0","volume":"56","author":"S Calanna","year":"2013","unstructured":"Calanna S, Christensen M, Holst JJ et al (2013) Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies. Diabetologia 56:965\u2013972","journal-title":"Diabetologia"},{"issue":"Suppl 2","key":"4265_CR31","first-page":"S137","volume":"39","author":"American Diabetes Association","year":"2016","unstructured":"American Diabetes Association (2016) II. Classification and diagnosis of diabetes. Diabetes Care 39(Suppl 2):S137\u2013S145","journal-title":"Diabetes Care"},{"issue":"Suppl 2","key":"4265_CR32","first-page":"B161","volume":"21","author":"BE Metzger","year":"1998","unstructured":"Metzger BE, Coustan DR (1998) Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 21(Suppl 2):B161\u2013B167","journal-title":"Diabetes Care"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-017-4265-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4265-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4265-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T08:31:05Z","timestamp":1496219465000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-017-4265-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,31]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["4265"],"URL":"https:\/\/doi.org\/10.1007\/s00125-017-4265-8","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,31]]}}}